Navigation Links
HRT Users Who Get Breast Cancer Less Likely to Die
Date:12/12/2008

They tend to get type of tumors that have better prognosis, study finds

FRIDAY, Dec. 12 (HealthDay News) -- Taking hormone therapy after menopause is known to increase the risk of getting breast cancer, but women who take hormone therapy and then develop breast cancer have a lower risk of dying from the disease, a new study suggests.

Why?

"Hormone therapy seems to give you a particular type of cancer that is easier to treat," explained study author Sarah F. Marshall, a senior statistician at the University of California Irvine. She is to report her finding on Saturday at the San Antonio Breast Cancer Symposium, in Texas.

"We found that women who took hormone therapy before their diagnosis were more likely to be diagnosed with estrogen receptor-positive cancer, as well as having breast cancers that were more favorable in other ways, [such as being] smaller and detected at an earlier stage," Marshall said.

Estrogen-receptor positive breast cancers depend on estrogen to grow. Giving anti-estrogen therapy (such as tamoxifen) treats the cancer.

Marshall and her colleagues evaluated almost 2,800 postmenopausal women who were diagnosed with a primary invasive breast cancer after joining the study in 1995 and 1996. The researchers then tracked outcomes through the end of 2005, or until the women's death.

"We looked at self-reported use of hormone therapy before their diagnosis," Marshall said. "We compared three groups -- those without [current or previous hormone use], those on estrogen alone, and those on estrogen-progestin."

Those taking estrogen-progestin had a 47 percent reduced risk of death from breast cancer during the follow-up compared to those who did not take hormone therapy. Those on estrogen alone had an 18 percent reduced risk of breast cancer death, but that was not statistically significant, she said.

The study results may be somewhat reassuring for women who took hormone replacement therapy, she said.

The finding is not surprising, said Dr. Victor G. Vogel, the incoming national vice president of research for the American Cancer Society and a professor of medicine and epidemiology at the University of Pittsburgh. "It says if you are taking HRT, your risk of getting breast cancer is higher, but your risk of dying from breast cancer is less," he said.

The finding may be surprising, he added, to those who don't appreciate the complex interaction between estrogen and breast cancer, which is still something of a paradox, he said.

In other presentations at the conference, researchers reported that:

  • Estrogen therapy may help women with metastatic breast cancer whose tumors stopped responding to anti-estrogen therapy. Giving the estrogen may return metastatic tumors to a vulnerable state after which patients can then be cycled back to the anti-estrogen therapy. The concept is not new, Vogel noted.
  • A switch to the drug anastrazole after one to four years of tamoxifen boosts disease-free survival by about 31 percent, according to another study, but patients report worse quality of life. But quality-of-life issues can generally be treated and improved, Vogel said.
  • The drug letrozole may beat out tamoxifen in improving overall survival in patients with primary breast cancer. A comparison study of the two found that letrozole reduces breast cancer recurrence and may decrease the risk of breast cancer death by 13 percent.

More information

To learn more about breast cancer, visit the American Cancer Society.



SOURCES: Victor G. Vogel, M.D., M.H.S., incoming national vice president, research, American Cancer Society, and professor, medicine and epidemiology, University of Pittsburgh; Sarah F. Marshall, senior statistician, University of California, Irvine; Dec. 12, 2008, presentation, San Antonio Breast Cancer Symposium, Texas


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. HCV and HBV spreading more slowly among injection drug users in San Francisco
2. New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users
3. Slowed Brain-Activity in Frequent Mobile Phone Users
4. Genes Might Predispose Antidepressant Users to Suicidal Thoughts
5. Defib Wire Warning Shouldnt Worry Most Users: Experts
6. National Magazine Ranks Highmark 62nd Among Nations 500 Most Innovative Users of Information Technology
7. IMG Announces an Affordable Full Screen Software Magnifier for Home and Business Users
8. National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Todays High-Tech World
9. Former substance abusers rarely relapse after organ transplantation
10. One Million PLAYSTATION(R)3 Users Participate in Folding@home Research Project
11. Microsoft Dynamics CRM 4.0 Users now can include Telephony and Call Recording features by adding ConversationPRO(TM) from VoiceGate, a Division of IgeaCare Systems Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HRT Users Who Get Breast Cancer Less Likely to Die
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
(Date:6/23/2016)... Ill. and INDIANAPOLIS , ... students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is ... 2016 scholarship winners, announced today online at www.diabetesscholars.org ... let type 1 diabetes stand in the way of ... has supported the Foundation,s scholarship program since 2012, and ...
Breaking Medicine Technology: